Under a collaborative research and exclusive license agreement, Receptor Logic will create custom TCRm in support of Sanofi Pasteur’s vaccine programs. Receptor Logic is funded and managed by life sciences venture firm, Emergent Technologies.
Tony Taylor, senior vice president, strategic planning at Emergent, said: “Receptor Logic has developed a powerful tool called T Cell Receptor Mimics (TCRm) aimed at measuring immune presentation. Sanofi Pasteur’s interest in this novel approach supports the potential value of this technology towards the development of vaccines and drugs in the future.”